Does tAK1-regulated expression of BIRC3 predict resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients?
The BIRC3 expression might be a valid biomarker for predicting patients with oesophageal adenocarcinoma that could most likely benefit from preoperative chemoradiotherapy.
Our data point toward an important role for miR-20a in the regulation of pro-inflammatory cytokines release, by controlling ASK1 expression in RA FLS.